Low expression of EXOSC2 protects against clinical COVID-19 and impedes SARS-CoV-2 replication. (2023)

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.26508/lsa.202201449

PubMed Identifier: 36241425

Publication URI: http://europepmc.org/abstract/MED/36241425

Type: Journal Article/Review

Volume: 6

Parent Publication: Life science alliance

Issue: 1

ISSN: 2575-1077